Morgan Stanley Downgrades ResMed (RMD) to Equalweight
Tweet Send to a FriendGet Alerts RMD Hot Sheet
Price: $49.98 --0%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 21 | New: 18
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 21 | New: 18
Trade RMD Now!
Earlier, Morgan Stanley downgraded ResMed (NYSE: RMD) from Overweight to Equalweight.
For more ratings news on ResMed click here and for the rating history of ResMed click here.
Shares of ResMed closed at $33.92 yesterday, with a 52 week range of $29.24-$70.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on ResMed click here and for the rating history of ResMed click here.
Shares of ResMed closed at $33.92 yesterday, with a 52 week range of $29.24-$70.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Macquarie Downgrades Franklin Resources (BEN) to Neutral
- Roth Capital Downgrades Acquity Group (AQ) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
